Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
The relationship between total and differential cell counts in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
The need of analysing induced sputum absolute cell counts in addition to cell percentages in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
A comparison of sputum induction methods Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Lack of correlation between BAL and induced sputum cell counts Source: Eur Respir J 2001; 18: Suppl. 33, 508s Year: 2001
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Establishing normal ranges for induced sputum cell counts in Singapore Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Improving automated cell recognition of sputum and BAL cells for Chipcytometry analysis Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006
A rapid method to increase the clinical use of sputum inflammatory cells Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
The effect of time elapsed since expectoration on sputum eosinophil differential cell counts Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
Treatment step-up strategy based on sputum eosinophil levels does not yield any better results than standard strategy Source: Eur Respir J 2005; 26: Suppl. 49, 574s Year: 2005
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 201s Year: 2003
Induced sputum: time from expectoration to processing Source: Eur Respir J 2002; 19: 706-708 Year: 2002
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Induced sputum: standardisation of methods and cell counts in a multi-centre trial Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 Year: 2021